Artigos de revistas sobre o tema "Inc National Cargo Bureau"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Inc National Cargo Bureau".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Lebwohl, M., A. Deodhar, S. Schwartzman, C. Salvarani, M. Feely, D. Zhu, P. Rahman et al. "AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 1780–81. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3412.
Texto completo da fonteMatsui, T., N. Sugiyama, S. Toyoizumi, F. Matsuyama, T. Murata, Y. Urata, K. Kawahata e S. Tohma. "POS0286 INCIDENCE OF MALIGNANCIES IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM A LARGE JAPANESE NATIONAL REGISTRY". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 368–69. http://dx.doi.org/10.1136/annrheumdis-2021-eular.365.
Texto completo da fonteBishop, Ryan T., Tao Li, Raghunandan R. Alugubelli, Oliver Hampton, Ariosto Siqueira Silva, Steven Grant, Kenneth H. Shain e Conor C. Lynch. "Acid Ceramidase (ASAH1) Mediates Intrinsic and Intercellular Transfer of Proteasome Inhibitor Resistance in Multiple Myeloma". Blood 138, Supplement 1 (5 de novembro de 2021): 1206. http://dx.doi.org/10.1182/blood-2021-152686.
Texto completo da fonteKhuat, Lam T., Catherine T. Le, Chien-Chun Pai, Robin Shields-Cutler, Shernan Holtan, Armin Rashidi, Sarah Parker et al. "Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation". Blood 134, Supplement_1 (13 de novembro de 2019): 1922. http://dx.doi.org/10.1182/blood-2019-127743.
Texto completo da fonteYijun, Liao, Li Ping e Huang Wenjing. "Research on the Impact of GNI on Express Delivery Volume in China". Journal of Economics and Public Finance 6, n.º 3 (12 de agosto de 2020): p110. http://dx.doi.org/10.22158/jepf.v6n3p110.
Texto completo da fonteNakazaki, Kumi, Toshiaki Takezaki, Yosuke Masamoto, Yasushi Miyazaki, Kinuko Mitani e Mineo Kurokawa. "A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan". Blood 138, Supplement 1 (5 de novembro de 2021): 4662. http://dx.doi.org/10.1182/blood-2021-146093.
Texto completo da fonteDiugwu, Ikechukwu A., Obioma R. Nwaogbe, Victor Omoke, Solomon T. Johnson e Ashem E. Egila. "Assessment of operational performance of public sector funded infrastructure in Nigeria: the airports perspective". Independent Journal of Management & Production 10, n.º 1 (1 de fevereiro de 2019): 133. http://dx.doi.org/10.14807/ijmp.v10i1.828.
Texto completo da fonteOjutalayo, John Folayan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu, Akujuobi Aghaegbulam Bonaventure Chidiebere e Theophilus Chinonyerem Nwokedi. "Poverty, Youth Unemployment, Maritime Piracy, and Sea Robbery in Nigeria between 1995 and 2013: A Relationship Assessment". Maritime Technology and Research 5, n.º 4 (13 de julho de 2023): 265349. http://dx.doi.org/10.33175/mtr.2023.265349.
Texto completo da fonteRubnitz, Jeffrey E., Thomas B. Alexander, Theodore W. Laetsch, Seong Lin Khaw, Vinod A. Pullarkat, Joseph T. Opferman, Kathryn G. Roberts et al. "Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma". Blood 136, Supplement 1 (5 de novembro de 2020): 12–13. http://dx.doi.org/10.1182/blood-2020-134582.
Texto completo da fonteCasulo, Carla, Michelle Byrtek, Keith L. Dawson, Xiaolei Zhou, Christopher R. Flowers, Charles M. Farber, John D. Hainsworth, James R. Cerhan, Brian K. Link e Jonathan W. Friedberg. "Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study". Blood 124, n.º 21 (6 de dezembro de 2014): 3044. http://dx.doi.org/10.1182/blood.v124.21.3044.3044.
Texto completo da fonteLee, Seung Tae, Antonio Pinto, Habte Yimer, Don Stevens, Wanda Knopinska Posluszny, Merrill Kingman Shum, Sudhir Manda et al. "A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)". Blood 138, Supplement 1 (5 de novembro de 2021): 1420. http://dx.doi.org/10.1182/blood-2021-150025.
Texto completo da fonteJourneycake, Janna M., Cedric Hermans, Jonathan M. Ducore, Miguel A. Escobar, Guy Young, Michael Wang, Doris Quon et al. "Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis". Blood 136, Supplement 1 (5 de novembro de 2020): 2–3. http://dx.doi.org/10.1182/blood-2020-136443.
Texto completo da fonteConnelly, K., R. Kandane-Rathnayake, V. Golder, W. Louthrenoo, Y. H. Chen, J. Cho, A. Lateef et al. "POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT". Annals of the Rheumatic Diseases 82, Suppl 1 (30 de maio de 2023): 1095.2–1096. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2885.
Texto completo da fonteSavage, Kerry J., Steven M. Horwitz, Ranjana H. Advani, Jacob H. Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser et al. "An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant". Blood 134, Supplement_1 (13 de novembro de 2019): 464. http://dx.doi.org/10.1182/blood-2019-122781.
Texto completo da fonteZinzani, Pier Luigi, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinska-Posluszny et al. "Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial". Blood 136, Supplement 1 (5 de novembro de 2020): 34–35. http://dx.doi.org/10.1182/blood-2020-134851.
Texto completo da fontePipe, Steven W., Michael Recht, Nigel S. Key, Frank W. G. Leebeek, Giancarlo Castaman, Susan U. Lattimore, Paul Van Der Valk et al. "First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies". Blood 136, Supplement_2 (19 de novembro de 2020): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2020-143560.
Texto completo da fonteKwak, Larry W., Juan Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim et al. "Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma". Blood 136, Supplement 1 (5 de novembro de 2020): 27–28. http://dx.doi.org/10.1182/blood-2020-135999.
Texto completo da fonteEscobar, Miguel A., Doris Quon, Cindy A. Leissinger, James V. Luck, Ahmad Al-Sabbagh, Daniel Bonzo, Ian S. Mitchell, W. Allan Alexander e Cedric Hermans. "PERSEPT3: A Phase 3 Clinical Trial to Evaluate the Hemostatic Efficacy of Eptacog Beta (Recombinant Human FVIIa) in Perioperative Care in Subjects with Hemophilia Α or B with Inhibitors". Blood 136, Supplement 1 (5 de novembro de 2020): 34–36. http://dx.doi.org/10.1182/blood-2020-136448.
Texto completo da fonteMatsuda, Kensuke, Taisuke Jo, Masashi Miyauchi, Kazuhiro Toyama, Kumi Nakazaki, Hideo Yasunaga e Mineo Kurokawa. "Primary Prophylaxis with Pegfilgrastim in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Nation-Wide, Propensity Score Based Analysis". Blood 134, Supplement_1 (13 de novembro de 2019): 1605. http://dx.doi.org/10.1182/blood-2019-123611.
Texto completo da fonteLee, Hun Ju, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano et al. "Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)". Blood 138, Supplement 1 (5 de novembro de 2021): 3534. http://dx.doi.org/10.1182/blood-2021-148779.
Texto completo da fonteMcGraw, Kathy L., Chia-Ho Cheng, Y. Ann Chen, Hsin-An Hou, Guilio Genovese, Thomas Cluzeau, Andrea Pellagatti et al. "SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition". Blood 132, Supplement 1 (29 de novembro de 2018): 107. http://dx.doi.org/10.1182/blood-2018-99-118747.
Texto completo da fonteWolach, Ofir, Itai Levi, Jonathan Canaani, Tamar Tadmor, Sigal Tavor, Ilana Hellmann, Tsila Zuckerman et al. "First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study". Blood 136, Supplement 1 (5 de novembro de 2020): 27–28. http://dx.doi.org/10.1182/blood-2020-139923.
Texto completo da fonteKernder, A., H. Morf, P. Klemm, D. Vossen, M. Meyer, I. Haase, J. Mucke et al. "POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de maio de 2021): 1013–14. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1328.
Texto completo da fonteGhia, Paolo, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Bryone J. Kuss, Stephen Opat, Ian W. Flinn et al. "First-Line Treatment with Ibrutinib (Ibr) Plus Venetoclax (Ven) for Chronic Lymphocytic Leukemia (CLL): 2-Year Post-Randomization Disease-Free Survival (DFS) Results from the Minimal Residual Disease (MRD) Cohort of the Phase 2 Captivate Study". Blood 138, Supplement 1 (5 de novembro de 2021): 68. http://dx.doi.org/10.1182/blood-2021-144544.
Texto completo da fonteGribben, John G., Wojciech Jurczak, Ryan W. Jacobs, Sebastian Grosicki, Krzysztof Giannopoulos, Tomasz Wrobel, Syed F. Zafar et al. "Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study". Blood 136, Supplement 1 (5 de novembro de 2020): 37–39. http://dx.doi.org/10.1182/blood-2020-134783.
Texto completo da fonteSchiller, Gary J., Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M. Chen e Mohamed M. Hegazi. "Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML". Blood 138, Supplement 1 (5 de novembro de 2021): 3412. http://dx.doi.org/10.1182/blood-2021-146018.
Texto completo da fonteCostello, Caitlin L., Tara K. Gregory, Syed Abbas Ali, Jesus G. Berdeja, Krina K. Patel, Nina D. Shah, Eric Ostertag et al. "Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)". Blood 134, Supplement_1 (13 de novembro de 2019): 3184. http://dx.doi.org/10.1182/blood-2019-129562.
Texto completo da fonteRollison, Dana E., Kenneth H. Shain, Ji-Hyun Lee, Shalaka S. Hampras, William Fulp, Kate Fisher, Najla H. Al Ali et al. "Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients". Blood 124, n.º 21 (6 de dezembro de 2014): 1912. http://dx.doi.org/10.1182/blood.v124.21.1912.1912.
Texto completo da fonteContributors. "ACKNOWLEDGMENTS". Acta Medica Philippina 54, n.º 6 (26 de dezembro de 2020). http://dx.doi.org/10.47895/amp.v54i6.2626.
Texto completo da fonteKANIA, MICHAL, BEATA KON, KONRAD M. KAMINSKI, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK e MACIEJ MALECKI. "1841-PUB: Diabetes as a Risk Factor of Death in Hospitalized COVID-19 Patients—An Analysis of a National Hospitalization Database from Poland, 2020". Diabetes 72, Supplement_1 (23 de junho de 2023). http://dx.doi.org/10.2337/db23-1841-pub.
Texto completo da fonteLEELARATHNA, LALANTHA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON et al. "951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study". Diabetes 72, Supplement_1 (20 de junho de 2023). http://dx.doi.org/10.2337/db23-951-p.
Texto completo da fonteFORLENZA, GREGORY P., SARAH A. MACLEISH, DOROTHY I. SHULMAN, BENJAMIN U. NWOSU, SIHAM ACCACHA, SATISH K. GARG, ANDERS L. CARLSON et al. "1901-LB: Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1901-lb.
Texto completo da fonteMAGLIANO, DIANNA J., LEI CHEN, JEDIDIAH I. MORTON, AGUS SALIM, BENDIX CARSTENSEN, EDWARD W. GREGG, MEDA E. PAVKOV et al. "1380-P: A Multicountry Analysis of Trends in Incidence of Young-Onset Type 2 Diabetes". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1380-p.
Texto completo da fonteCHEPP, VALERIE, STEVEN P. MASIANO, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE e ANITA D. MISRA-HEBERT. "1125-P: Provider Experience Caring for Elderly Patients with Uncontrolled Type 2 Diabetes and Hospitalization". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1125-p.
Texto completo da fonteOjutalayo, John Folamyan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu e Theophilus Chinonyerem Nwokedi. "Study on the Effects of Maritime Piracy and Sea Robbery on Economic Growth in Nigeria". International Journal of Social Science and Research 1, n.º 1 (6 de setembro de 2023). http://dx.doi.org/10.58531/ijssr/1/1/2.
Texto completo da fonteVIGERSKY, ROBERT A., BRUCE W. BODE, RONALD L. BRAZG, BRUCE A. BUCKINGHAM, ANDERS L. CARLSON, KEVIN B. KAISERMAN, MARK KIPNES et al. "100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-100-lb.
Texto completo da fonteBARNARD, KATHARINE, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON et al. "633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study". Diabetes 72, Supplement_1 (20 de junho de 2023). http://dx.doi.org/10.2337/db23-633-p.
Texto completo da fonteMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1895-lb.
Texto completo da fonteMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI et al. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1896-lb.
Texto completo da fonteWEINSTOCK, RUTH S., ZACHARY THOMPSON, RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER et al. "263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits". Diabetes 72, Supplement_1 (20 de junho de 2023). http://dx.doi.org/10.2337/db23-263-or.
Texto completo da fonteMASIANO, STEVEN P., LARISA G. TERESHCHENKO, VALERIE CHEPP, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE e ANITA D. MISRA-HEBERT. "1111-P: Predictors of Type 2 Diabetes (T2D) Medication Change and Improved A1C among Older Adults Post-hospitalization". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-1111-p.
Texto completo da fonteMILLER, KELLEE, HUYEN NGUYEN, JENNIFER L. SHERR, YOGISH C. KUDVA, ANDERS L. CARLSON, NAOMI CHAYTOR, DANIEL DESALVO et al. "265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-265-or.
Texto completo da fonteBODE, BRUCE W., TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST et al. "672-P: Performance of a New Disposable Zero-Calibration Continuous Glucose Monitoring (CGM) Sensor". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-672-p.
Texto completo da fonteFAULDS, EILEEN R., YASAMAN BADAKHSHI, ANDREW BOUTSICARIS, MATTHEW C. EXLINE, JOI HESTER, LAUREEN G. JONES, MOLLY MCNETT et al. "230-OR: Hybrid Continuous Glucose Monitoring Protocols in the Intensive Care Unit—Multicenter Experience". Diabetes 72, Supplement_1 (20 de junho de 2023). http://dx.doi.org/10.2337/db23-230-or.
Texto completo da fonteEBERT, THOMAS, NOSHEEN SATTAR, MARNI GREIG, CLAUDIA LAMINA, MARC FROISSART, KAI-UWE ECKARDT, JÜRGEN FLOEGE et al. "808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-808-p.
Texto completo da fonteDUBSKY, MICHAL, ROBERT ROLAND, NATÁLIA MARHEFKOVÁ, PETER WOHLFAHRT, PETER NOVODVORSKY, VLADIMIR KARMAZIN, MARTIN HALUZIK e MICHAL PAZDERNIK. "185-OR: The Role of Optical Coherent Tomography in the Estimation of Cardiovascular Risk in Asymptomatic Patients with Type 1 Diabetes". Diabetes 73, Supplement_1 (14 de junho de 2024). http://dx.doi.org/10.2337/db24-185-or.
Texto completo da fonteDESHMUKH, HARSHAL, BEATRICE PIERI, EMMA G. WILMOT, PRATIK CHOUDHARY, NAJEEB SHAH, VASILEIOS TSATLIDIS, ALISTAIR N. LUMB, ROBERT E. RYDER, CHRISTOPHER WALTON e THOZHUKAT SATHYAPALAN. "90-OR: FreeStyle Libre (FSL) Time in Range (TIR) and Time Below Range (TBR) : Impact on HbA1c, Diabetes-Related Distress (DRD) , and Resource Utilisation in the Association of British Clinical Diabetologists (ABCD) National Audit". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-90-or.
Texto completo da fonteFORLENZA, GREGORY P., BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, SUE A. BROWN, RUTH S. WEINSTOCK, DAVID W. HANSEN et al. "766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-766-p.
Texto completo da fonteSCHOELWER, MELISSA, BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, GREGORY P. FORLENZA, RUTH S. WEINSTOCK, DAVID W. HANSEN et al. "765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years". Diabetes 71, Supplement_1 (1 de junho de 2022). http://dx.doi.org/10.2337/db22-765-p.
Texto completo da fonteHOOD, KOREY K., RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER, MARY L. JOHNSON et al. "1031-P: Virtual Clinic Support—Patient-Reported Outcome Benefits". Diabetes 72, Supplement_1 (20 de junho de 2023). http://dx.doi.org/10.2337/db23-1031-p.
Texto completo da fonte